Boundless Bio, Inc. Operating Cash Flow for the Trailing 12 Months (TTM) ending December 31, 2024: USD -60.84 M

Boundless Bio, Inc. Operating Cash Flow is USD -60.84 M for the Trailing 12 Months (TTM) ending December 31, 2024, a 29.85% change year over year. Operating cash flow is cash generated from the company’s regular business operations.
  • Boundless Bio, Inc. Operating Cash Flow for the Trailing 12 Months (TTM) ending December 31, 2023 was USD -46.85 M.
Key Data
Date Operating Cash Flow Capital Expenditure Net Cash Used For Investing Activities Net Cash Used Provided By Financing Activities